Trial Profile
A trial of CERC 501 in treatment of mood disorders
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Aticaprant (Primary)
- Indications Mood disorders
- Focus Therapeutic Use
- 30 Mar 2016 New trial record